AimPlex Biosciences, Inc. leverages years of assay development expertise to offer comprehensive solutions in biomedical testing. Founded in August 2011, the company is committed to developing and providing high-quality, cost-effective immunoassay reagents for flow cytometry analyses. Our immunoassay products employ existing flow cytometry analytical platforms for sensitive detection. AimPlex Bio offers a rapidly-evolving, customizable test menu, as well as custom immunoassay services to develop new multiplex assay panels to improve customer assay performance and efficiency. Currently, we offer over 400 non-Luminex* bead-based immunoassays for conventional flow cytometers such as the Accuri C6*, FACSCalibur*, FACSCanto*, LSRII*, CyAn*, EC800* and FC500*. *Trademarks are the property of their respective owners.
View Top Employees from AimPlex Biosciences, Inc.Website | http://www.aimplexbio.com |
Revenue | $200000 |
Employees | 4 (4 on RocketReach) |
Founded | 2011 |
Address | 2265 E. Foothill Blvd, Pasadena, California 91107, US |
Phone | (714) 391-1028 |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Biotechnology, Medical Testing & Clinical Laboratories, Healthcare |
SIC | SIC Code 8071 Companies, SIC Code 807 Companies, SIC Code 80 Companies |
NAICS | NAICS Code 621 Companies, NAICS Code 62 Companies |
Looking for a particular AimPlex Biosciences, Inc. employee's phone or email?
The AimPlex Biosciences, Inc. annual revenue was $200000 in 2024.
David Hocking is the Vice President Sales and Marketing of AimPlex Biosciences, Inc..
4 people are employed at AimPlex Biosciences, Inc..
AimPlex Biosciences, Inc. is based in Pasadena, California.
The NAICS codes for AimPlex Biosciences, Inc. are [621, 62].
The SIC codes for AimPlex Biosciences, Inc. are [8071, 807, 80].